CARMEN AYALA: Open Payments
NPI 1649426750 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,144 in 40 payments from 12 companies in 2025. Trend: 2023 $1,318 · 2024 $993 · 2025 $1,144
Food & beverage: $1,144
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $293 |
| AstraZeneca Pharmaceuticals LP | 7 | $263 |
| Novo Nordisk Inc | 6 | $148 |
| Lilly USA, LLC | 4 | $90 |
| PFIZER INC. | 4 | $84 |
| Exact Sciences Corporation | 3 | $82 |
| Abbott Laboratories | 2 | $47 |
| Amgen Inc. | 2 | $39 |
| Dexcom, Inc. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $25 |
Products named: QULIPTA, AIRSUPRA, MOUNJARO, PREVNAR 20, Ozempic, Cologuard Collection Kit, UBRELVY, FREESTYLE LIBRE.
Industry payments across VA — which companies pay providers there.
